FDA Orange Book

Is there a generic for Trudhesa?

Trudhesa contains dihydroergotamine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Trudhesa (dihydroergotamine). The Orange Book shows its last listed patent expires January 4, 2039.

Run it in Rivvi

Map Trudhesa and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Trudhesa products in the Orange Book

Trudhesa products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
spray, metered, nasal0.725MG/SPRAYMarketed (Rx)None0None

NDA 213436, held by IMPEL PHARMACEUTICALS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Trudhesa patents

Patents listed for Trudhesa
PatentExpiresCoversUse codeNDA
9550036September 5, 2032Drug productNone213436
10507295December 25, 2032Drug productNone213436
10940278January 23, 2033Drug productNone213436
9919117March 17, 2033Drug productU-3218213436
11266799November 5, 2036Drug productNone213436
11185497January 4, 2039Method of useU-3218213436

Trudhesa NDC codes

Questions

Is there a generic for Trudhesa?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Trudhesa (dihydroergotamine). The Orange Book shows its last listed patent expires January 4, 2039.

What is the generic name for Trudhesa?

The active ingredient in Trudhesa is dihydroergotamine, per the FDA Orange Book.

When does the Trudhesa patent expire?

The last patent listed for Trudhesa in the Orange Book expires January 4, 2039. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Trudhesa and Dihydroergotamine

Try it on your own data today.

Free to start. Most teams are using it the same day.